Annual Cash & Cash Equivalents
$987.23M$491.92M+99.31%
Summary
- Current Value
- As of today, RPRX annual cash & cash equivalents is $987.23M, up +99.31% on
- Historical Performance
- RPRX annual cash & cash equivalents is down -54.90% over the past 3 years, and up +189.80% over the past 5 years
- All-Time High Comparison
- RPRX annual cash & cash equivalents is currently -54.90% below its historical high of $2.19B set on
- 3-Year Low Comparison
- RPRX annual cash & cash equivalents is +99.31% above its 3-year low of $495.31M reached on
- Sector Comparison
- RPRX annual cash & cash equivalents is higher than 93.47% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $987.23M | +99.3% | -54.9% | +189.8% | -42.6% | |
| Quarterly Cash & Cash Equivalents | $955.04M | -4.4% | -38.0% | -56.1% | – | |
| Price | $39.83 | +29.6% | +1.2% | -23.3% | – | |
| Annual Current Assets | $1.80B | +41.4% | -37.4% | +116.6% | -40.8% | |
| Annual Total Liabilities | $7.88B | +25.1% | +8.4% | +24.9% | +28.8% | |
| Annual Working Capital | $548.52M | -50.7% | -79.7% | +10.0% | -79.9% | |
| Annual Net Income | $1.33B | -21.7% | +7.2% | -45.9% | +75.4% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.74B | N/A | -43.1% |
| 5Y | $2.19B | -54.9% | |
| All | $2.19B | -54.9% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $495.31M | +99.3% | |
| 5Y | $495.31M | +99.3% | |
| All | $340.65M | +189.8% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $987.23M | +99.3% | |
| $495.31M | -71.5% | |
| $1.74B | -20.7% | |
| $2.19B | +6.2% | |
| $2.06B | +505.3% |
| Year | Value | Change |
|---|---|---|
| $340.65M | -82.3% | |
| $1.92B | +39.3% | |
| $1.38B | -17.5% | |
| $1.67B | -2.7% | |
| $1.72B | - |
FAQ
What is the current annual cash & cash equivalents of RPRX?
As of today, RPRX annual cash & cash equivalents is $987.23M
What is 1-year change in RPRX annual cash & cash equivalents?
RPRX annual cash & cash equivalents is up +99.31% year-over-year
What is 3-year change in RPRX annual cash & cash equivalents?
RPRX annual cash & cash equivalents is down -54.90% over the past 3 years
How far is RPRX annual cash & cash equivalents from its all-time high?
RPRX annual cash & cash equivalents is currently -54.90% below its historical high of $2.19B set on December 31, 2021
How does RPRX annual cash & cash equivalents rank versus sector peers?
RPRX annual cash & cash equivalents is higher than 93.47% of companies in Healthcare sector
When is RPRX next annual earnings release?
The next annual earnings release for RPRX is on
Quarterly Cash & Cash Equivalents
$955.04M$309.94M+48.04%
Summary
- Current Value
- As of today, RPRX quarterly cash & cash equivalents is $955.04M, up +48.04% on
- Historical Performance
- RPRX quarterly cash & cash equivalents is down -4.36% year-over-year, and down -38.02% over the past 3 years
- All-Time High Comparison
- RPRX quarterly cash & cash equivalents is currently -66.08% below its historical high of $2.82B set on
- 3-Year Low Comparison
- RPRX quarterly cash & cash equivalents is +92.82% above its 3-year low of $495.31M reached on
- Sector Comparison
- RPRX quarterly cash & cash equivalents is higher than 92.31% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $955.04M | +48.0% | -4.4% | -38.0% | -56.1% | |
| Annual Cash & Cash Equivalents | $987.23M | – | +99.3% | -54.9% | +189.8% | |
| Price | $39.83 | +10.1% | +29.6% | +1.2% | -23.3% | |
| Quarterly Current Assets | $1.85B | +21.7% | +3.1% | -21.0% | -33.6% | |
| Quarterly Total Liabilities | $9.73B | +10.3% | +25.0% | +34.0% | +57.1% | |
| Quarterly Working Capital | $1.32B | +320.4% | +110.5% | +8.9% | -47.5% | |
| Quarterly Net Income | $444.21M | +390.1% | -44.9% | +101.5% | -28.8% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.10B | -13.2% | |
| 3Y | $2.18B | -56.1% | |
| 5Y | $2.76B | -65.4% | |
| All | $2.82B | -66.1% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $645.11M | +48.0% | |
| 3Y | $495.31M | +92.8% | |
| 5Y | $495.31M | +92.8% | |
| All | $340.65M | +180.4% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of RPRX?
As of today, RPRX quarterly cash & cash equivalents is $955.04M
What is RPRX quarterly cash & cash equivalents most recent change?
RPRX quarterly cash & cash equivalents was up +48.04% on September 30, 2025
What is 1-year change in RPRX quarterly cash & cash equivalents?
RPRX quarterly cash & cash equivalents is down -4.36% year-over-year
How far is RPRX quarterly cash & cash equivalents from its all-time high?
RPRX quarterly cash & cash equivalents is currently -66.08% below its historical high of $2.82B set on June 30, 2020
How does RPRX quarterly cash & cash equivalents rank versus sector peers?
RPRX quarterly cash & cash equivalents is higher than 92.31% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx